{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:03:17Z","timestamp":1789380197955,"version":"build-2803163510"},"reference-count":13,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BioClinica, Inc","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Araclon Biotech","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100002565","name":"Alzheimer\u2019s Drug Discovery Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DOD ADNI","award":["W81XWH-12-2-0012"],"award-info":[{"award-number":["W81XWH-12-2-0012"]}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) - National Institutes of Health","award":["U01AG024904"],"award-info":[{"award-number":["U01AG024904"]}]},{"name":"Transition Therapeutics","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Cogstate","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"CereSpir, Inc.","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Bristol-Myers Squibb Company","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2026,5,31]]},"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anti-amyloid therapies for Alzheimer\u2019s disease (AD) require efficient patient selection. The Clinical Dementia Rating (CDR) scale is the reference standard for staging, but it is time-consuming to administer. Simple tools to distinguish early-stage cognitive impairment (CDR 0.5\u20131) from more advanced stages (CDR 2\u20133)\u2009would therefore be of substantial clinical value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) cohorts 1\u20133 with CDR \u22650.5 were analysed. Three logistic regression models using Mini\u2013Mental State Examination (MMSE), Functional Assessment Questionnaire (FAQ) or the FAQ\/MMSE ratio as predictors were developed. Two cut-offs per model were selected to ensure minimum sensitivity and specificity of 0.99, defining rule-out, rule-in and intermediate (uncertain) zones. Performance was assessed using discrimination, calibration and decision curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1533 ADNI participants with CDR \u22650.5, two-thirds (n=1022) were assigned to the training set and one-third (n=511) to the test set. FAQ\/MMSE and FAQ showed excellent discrimination (area under the curve, AUC 0.97\u20130.98), outperforming MMSE (AUC 0.94\u20130.95). FAQ\/MMSE demonstrated the best overall performance, although differences compared with FAQ were small and not statistically significant. Dual cut-offs for FAQ\/MMSE (0.67 and 1.44) and FAQ (12 and 27) enabled clinically meaningful stratification, with 80% and 70% of participants classified into high-confidence zones, respectively. Results were consistent across the training and test sets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The FAQ\/MMSE ratio and FAQ score show high accuracy in distinguishing early-stage (CDR 0.5\u20131) from more advanced cognitive impairment (CDR 2\u20133). These simple measures may support the clinical preselection of patients for further evaluation in the context of anti-amyloid therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2026-338997","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:27:50Z","timestamp":1783013270000},"page":"869-872","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic accuracy of a two-cut-off approach using the FAQ\/MMSE ratio and FAQ for clinical preselection of patients for anti-amyloid therapy"],"prefix":"10.1136","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7438-8763","authenticated-orcid":false,"given":"Adolfo","family":"Jim\u00e9nez-Huete","sequence":"first","affiliation":[{"name":"Department of Neurology, Cl\u00ednica Universidad de Navarra, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5430-3830","authenticated-orcid":false,"given":"Teresa","family":"Rognoni","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cl\u00ednica Universidad de Navarra, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3994-8993","authenticated-orcid":false,"given":"Genoveva","family":"Montoya","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cl\u00ednica Universidad de Navarra, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5832-0603","authenticated-orcid":false,"given":"Miguel Germ\u00e1n","family":"Borda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cl\u00ednica Universidad de Navarra, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4383-9127","authenticated-orcid":false,"given":"Mario","family":"Riverol","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cl\u00ednica Universidad de Navarra, Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Navarra (IdisNA), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"2026091402101030000_97.10.869.1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207757"},{"key":"2026091402101030000_97.10.869.2","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0140-6736(25)01329-7","article-title":"Treatment for Alzheimer\u2019s disease","volume":"406","author":"Fox","year":"2025","journal-title":"Lancet"},{"key":"2026091402101030000_97.10.869.3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.11.2412-a"},{"key":"2026091402101030000_97.10.869.4","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/37.3.323"},{"key":"2026091402101030000_97.10.869.5","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"2026091402101030000_97.10.869.6","unstructured":"R Core Team . R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2024. Available: https:\/\/www.R-project.org\/"},{"key":"2026091402101030000_97.10.869.7","unstructured":"The ADNI team . ADNIMERGE: Alzheimer\u2019s Disease Neuroimaging (R package version 0.0.1). Available: https:\/\/cran.r-project.org\/package=ADNIMERGE"},{"key":"2026091402101030000_97.10.869.8","doi-asserted-by":"crossref","unstructured":"Lopez-Raton M , Rodriguez-Alvarez MX , Cadarso Suarez C , et al . OptimalCutpoints: an r package for selecting optimal cutpoints in diagnostic tests. J Stat Softw 2014;1\u201336. doi:10.18637\/jss.v061.i08","DOI":"10.18637\/jss.v061.i08"},{"key":"2026091402101030000_97.10.869.9","unstructured":"Sjoberg D . Dcurves: decision curve analysis for model evaluation (R package version 0.5.1). Available: https:\/\/CRAN.R-project.org\/package=dcurves"},{"key":"2026091402101030000_97.10.869.10","doi-asserted-by":"publisher","DOI":"10.1097\/01.JGP.0000192478.82189.a8"},{"key":"2026091402101030000_97.10.869.11","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70163","article-title":"Extension and external validation of mapping between the Mini-Mental State Examination and the Clinical Dementia Rating scale in patients with Alzheimer\u2019s disease","volume":"21","author":"Brogaard","year":"2025","journal-title":"Alzheimers Dement"},{"key":"2026091402101030000_97.10.869.12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/1073191121991215","article-title":"Comprehensive Evaluation of the Functional Activities Questionnaire (FAQ) and Its Reliability and Validity","volume":"29","author":"Gonz\u00e1lez","year":"2022","journal-title":"Assessment"},{"key":"2026091402101030000_97.10.869.13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3233\/JAD-231426","article-title":"Simplifying Alzheimer\u2019s Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire","volume":"99","author":"Sato","year":"2024","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2026-338997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:10:28Z","timestamp":1789377028000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2026-338997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":13,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,14]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/jnnp-2026-338997"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2026-338997","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}